A non‐contact suspension culture approach to the culture of osteogenic cells derived from a CD49elow subpopulation of human bone marrow‐derived cells

We demonstrate that adult human bone marrow (BM) contains a population of mesenchymal stromal cells (MSCs) that can be expanded in non‐adherent, cytokine‐dependent, suspension culture conditions for at least 42 days. The cells generated during suspension culture lacked detectable levels of gene expression associated with differentiated mesenchymal cell types, including bone, muscle and fat, suggesting that suspension culture maintains MSCs in an uncommitted state. However, when these undifferentiated cells were taken out of suspension culture and placed in adherent osteogenic conditions, osteogenic genes were upregulated and morphologically identifiable bone matrix was elaborated. Flow cytometric analysis of uncultured, density gradient‐separated human BM revealed that colony forming unit‐fibroblast (CFU‐F) and CFU‐osteoblast (CFU‐O) activity was associated with a CD45− CD49elow phenotype. Importantly, suspension‐grown MSCs, capable of CFU‐F and CFU‐O development, maintained the CD45−CD49elow phenotype whereas MSCs directly cultured under adherent conditions rapidly upregulated CD49e expression and were associated with a CD45−CD49ehigh phenotype. Tracking the CD49elow expression under suspension culture conditions provides a mechanism to isolate an expanding suspension‐grown MSC population with osteogenic potential. This could provide a potential strategy to isolate populations of MSCs, with functional osteogenic capacity, in a scalable and controllable culture system for therapeutic applications. Biotechnol. Bioeng. 2007;98: 1195–1208. © 2007 Wiley Periodicals, Inc.

[1]  D. Marsh,et al.  Nonadherent cell population of human marrow culture is a complementary source of mesenchymal stem cells (MSCs) , 2006, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[2]  Peter W Zandstra,et al.  Soluble factor cross-talk between human bone marrow-derived hematopoietic and mesenchymal cells enhances in vitro CFU-F and CFU-O growth and reveals heterogeneity in the mesenchymal progenitor cell compartment. , 2005, Blood.

[3]  M. Andreeff,et al.  Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. , 2004, Journal of the National Cancer Institute.

[4]  D. Scadden,et al.  Osteoblastic cells regulate the haematopoietic stem cell niche , 2003, Nature.

[5]  J. Davies,et al.  Adult human bone marrow-derived mesenchymal progenitor cells are capable of adhesion-independent survival and expansion. , 2003, Experimental hematology.

[6]  P. Hervé,et al.  Direct selection of human bone marrow mesenchymal stem cells using an anti‐CD49a antibody reveals their CD45med,low phenotype , 2003, British journal of haematology.

[7]  L. Bonewald,et al.  Von Kossa Staining Alone Is Not Sufficient to Confirm that Mineralization In Vitro Represents Bone Formation , 2003, Calcified Tissue International.

[8]  S. Gronthos,et al.  Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow , 2003, Journal of Cell Science.

[9]  C. Cobbs,et al.  Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. , 2003, Blood.

[10]  R. J. Dumont,et al.  Human mesenchymal stem cells transduced with recombinant bone morphogenetic protein-9 adenovirus promote osteogenesis in rodents. , 2003, Tissue engineering.

[11]  David L Butler,et al.  In vivo forces used to develop design parameters for tissue engineered implants for rabbit patellar tendon repair. , 2003, Journal of biomechanics.

[12]  J. Falkenburg,et al.  Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. , 2002, Experimental hematology.

[13]  Cun-Yu Wang,et al.  Bone formation by human postnatal bone marrow stromal stem cells is enhanced by telomerase expression , 2002, Nature Biotechnology.

[14]  J. Huard,et al.  Muscle-derived stem cells , 2002, Gene Therapy.

[15]  A. Caplan,et al.  The STRO-1+ Marrow Cell Population Is Multipotential , 2001, Cells Tissues Organs.

[16]  A. Garnier,et al.  Scale-up of a myoblast culture process. , 2001, Journal of biotechnology.

[17]  J. Gimble,et al.  Surface protein characterization of human adipose tissue‐derived stromal cells , 2001, Journal of cellular physiology.

[18]  M. Mastrogiacomo,et al.  Effect of different growth factors on the chondrogenic potential of human bone marrow stromal cells. , 2001, Osteoarthritis and cartilage.

[19]  A. Caplan,et al.  The Dynamic in vivo Distribution of Bone Marrow-Derived Mesenchymal Stem Cells after Infusion , 2001, Cells Tissues Organs.

[20]  G. Almeida-Porada,et al.  Evaluation of serum-free culture conditions able to support the ex vivo expansion and engraftment of human hematopoietic stem cells in the human-to-sheep xenograft model. , 2000, Journal of hematotherapy & stem cell research.

[21]  R L Juliano,et al.  Cell adhesion molecules, signal transduction and cell growth. , 1999, Current opinion in cell biology.

[22]  A I Caplan,et al.  Chondroprogenitor cells of synovial tissue. , 1999, Arthritis and rheumatism.

[23]  S. Goldstein,et al.  Marrow‐derived progenitor cell injections enhance new bone formation during distraction , 1999, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[24]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[25]  Darwin J. Prockop,et al.  Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta , 1999, Nature Medicine.

[26]  J. Aubin Osteoprogenitor cell frequency in rat bone marrow stromal populations: Role for heterotypic cell–cell interactions in osteoblast differentiation , 1999, Journal of cellular biochemistry.

[27]  G Cossu,et al.  Muscle regeneration by bone marrow-derived myogenic progenitors. , 1998, Science.

[28]  R. Midura,et al.  Characterization of human bone marrow stromal cells with respect to osteoblastic differentiation , 1997, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[29]  G. Gyapay,et al.  Human desmin gene: cDNA sequence, regional localization and exclusion of the locus in a familial desmin-related myopathy , 1996, Human Genetics.

[30]  J. Davies In vitro modeling of the bone/implant interface , 1996, The Anatomical record.

[31]  C. Verfaillie,et al.  Direct contact with stroma inhibits proliferation of human long-term culture initiating cells. , 1996, Leukemia.

[32]  M. Koller,et al.  Long-term culture-initiating cell expansion is dependent on frequent medium exchange combined with stromal and other accessory cell effects. , 1995, Blood.

[33]  O. Bagasra,et al.  Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[34]  C. Verfaillie,et al.  Direct contact between human primitive hematopoietic progenitors and bone marrow stroma is not required for long-term in vitro hematopoiesis. , 1992, Blood.

[35]  S. Emerson,et al.  Rapid medium perfusion rate significantly increases the productivity and longevity of human bone marrow cultures. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[36]  B. Greenberg,et al.  Granulopoietic Effects of Human Bone Marrow Fibroblastic Cells and Abnormalities in the "Granulopoietic Microenvironment" , 1981 .

[37]  H. Broxmeyer,et al.  Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. , 1980, Blood.

[38]  A. Friedenstein,et al.  THE DEVELOPMENT OF FIBROBLAST COLONIES IN MONOLAYER CULTURES OF GUINEA‐PIG BONE MARROW AND SPLEEN CELLS , 1970, Cell and tissue kinetics.

[39]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[40]  F. Marini,et al.  Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. , 2005, Cytotherapy.

[41]  A. Tocci,et al.  Mesenchymal stem cell: use and perspectives. , 2003, The hematology journal : the official journal of the European Haematology Association.

[42]  Tetsuya Tateishi,et al.  Mesenchymal stem cells and bioceramics: strategies to regenerate the skeleton. , 2003, Novartis Foundation symposium.

[43]  Paul D. Kessler,et al.  Human Mesenchymal Stem Cells Differentiate to a Cardiomyocyte Phenotype in the Adult Murine Heart , 2002, Circulation.

[44]  S. Han,et al.  Novel expression and function of peroxisome proliferator-activated receptor gamma (PPARgamma) in human neuroblastoma cells. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[45]  S. Gerson,et al.  Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[46]  G. Kemp,et al.  Calcium and orthophosphate deposits in vitro do not imply osteoblast-mediated mineralization: mineralization by betaglycerophosphate in the absence of osteoblasts. , 1990, Bone.